Previous close | 28,659.00 |
Open | 28,399.00 |
Bid | 28,472.00 x 0 |
Ask | 28,635.50 x 0 |
Day's range | 28,399.00 - 28,899.00 |
52-week range | 10,463.50 - 34,225.00 |
Volume | |
Avg. volume | 1,151 |
Market cap | 284.634T |
Beta (5Y monthly) | 0.40 |
PE ratio (TTM) | 3.62 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 346.29 (1.21%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | N/A |
RAHWAY, N.J., May 01, 2024--Merck Announces KEYNOTE-811 Trial Met Dual Primary Endpoint as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or GEJ Cancer
RAHWAY, N.J., April 29, 2024--Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
RAHWAY, N.J., April 25, 2024--Merck Announces First-Quarter 2024 Financial Results